Association of vitamin D receptor genotype with leprosy type

Journal of Infectious Diseases

Volumn 179, Issue 1, 1999, Pages 187-191

  Roy, Suchismita ^a   Frodsham, A ^b   Saha, B ^b   Hazra, S K ^b   Mascie Taylor, C G N ^b   Hill, A V S ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

VITAMIN D RECEPTOR;

ARTICLE; CONTROLLED STUDY; GENETIC ASSOCIATION; GENOTYPE; HOST SUSCEPTIBILITY; HUMAN; INDIA; LEPROMATOUS LEPROSY; LUNG TUBERCULOSIS; MACROPHAGE; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; OSTEOPOROSIS; PRIORITY JOURNAL; RECEPTOR GENE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; TUBERCULOID LEPROSY;

ALLELES; BASE SEQUENCE; CARRIER PROTEINS; CASE-CONTROL STUDIES; CATION TRANSPORT PROTEINS; DNA PRIMERS; GENE FREQUENCY; GENOTYPE; HUMANS; IMMUNOGENETICS; INDIA; LEPROSY; LEPROSY, LEPROMATOUS; LEPROSY, TUBERCULOID; MEMBRANE PROTEINS; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; SEQUENCE DELETION; VARIATION (GENETICS);

EID: 0032946201     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314536     Document Type: Article

References (25)

1. de Vries RR, Fat RF, Nijenhuis LE, van Rood JJ. HLA-linked genetic control of host response to Mycobacterium leprae. Lancet 1976; 2:1328-30.
2. Fine PE. Immunogenetics of susceptibility to leprosy, tuberculosis, and leishmaniasis. An epidemiological perspective. Int J Lepr 1981; 49:437-54.
3. Todd JR, West BC, McDonald JC. Human leukocyte antigens and leprosy: study in northern Louisiana and review. Rev Infect Dis 1990; 12:63-74.
4. van Eden W, de Vries RR, Mehra NK, Vaidya MC, D'Amaro J, van Rood JJ. HLA segregation of tuberculoid leprosy: confirmation of the DR2 marker. J Infect Dis 1980; 141:693-701.
5. Rani R, Fernandez Vina MA, Zaheer SA, Beena KR, Stastny P. Study of HLA class II alleles by PCR oligotyping in leprosy patients from North India. Tissue Antigens 1993; 42:133-7.
6. Rigby WF. The immunobiology of vitamin D. Immunol Today 1988; 9:54-58.
7. Morrison NA, Qi JC, Tokita A, et al. Prediction of bone density from vitamin D receptor. Nature 1994; 367:284-7.
8. Morrison NA, Yeoman R, Kelly PJ, Eisman JA. Contribution of trans-acting factor alleles to normal physiological variability: vitamin D receptor gene polymorphism and circulating osteocalcin. Proc Natl Acad Sci USA 1992; 89:6665-9.
9. Carling T, Kindmark A, Hellman P, et al. Vitamin D receptor genotypes in primary hyperparathyroidism. Nat Med 1995; 1:1309-11.
10. Tsukamoto Y, Heishi M, Nagaba Y, et al. More on hyperparathyroidism and the vitamin D receptor. Nat Med 1996; 2:1162.
11. Taylor JA, Hirovnen A, Watson M, Pittman G, Mohler JL, Bell DA. Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res 1996; 56:4108-10.
12. Blackwell JM. The macrophage resistance gene Lsh/Ity/Bcg. Res Immunol 1989; 140:767-9.
13. Liu J, Fujiwara TM, Buu NT, et al. Identification of polymorphisms and sequence variants in the human homologue of the mouse natural resistance-associated macrophage protein gene. Am J Hum Genet 1995; 56:845-53.
14. Blackwell JM, Barton CH, White JK, et al. Genomic organization and sequence of the human NRAMP gene: identification and mapping of a promoter region polymorphism. Mol Med 1995; 1:194-205.
15. White JK, Shaw MA, Barton CH, et al. Genetic and physical mapping of 2q35 in the region of the NRAMP and IL8R genes: identification of a polymorphic repeat in exon 2 of NRAMP. Genomics 1994; 24:295-302.
16. Roger M, Levee G, Chanteau S, Gicquel B, Schurr E. No evidence for linkage between leprosy susceptibility and the human natural resistance-associated macrophage protein 1 (NRAMP1) gene in French Polynesia. Int J Lepr Other Mycobact Dis 1997; 65:197-202.
17. Abel L, Sanchez FO, Oberti J, et al. Susceptibility to leprosy is linked to the human NRAMP1 gene. J Infect Dis 1998; 177:133-145.
18. Bellamy R, Ruwende C, Corrah T, McAdam KP, Whittle HC, Hill AV. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans. N Engl J Med 1998; 338:640-4.
19. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988; 16:1215.
20. Rook GA, Steele J, Fraher L, et al. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986; 57:159-63.
21. Rogers L. Chaulmoogra oil in leprosy and tuberculosis. Lancet 1921; 1:1178-80.
22. Eisman JA. Vitamin D receptor gene variants: implications for therapy. Curr Opin Genet Develop 1996; 6:361-5.
23. Misra N, Murtaza A, Walker B, et al. Cytokine profile of circulating T cells in leprosy patients reflects both indiscriminate and polarized T-helper subsets. Immunology 1995; 86:97-103.
24. Yamamura M, Uyemura K, Deans RJ, et al. Defining protective responses to pathogens: cytokine profiles in leprosy lesions. Science 1991; 254:277-9.
25. Shaw MA, Atkinson S, Dockrell H, et al. An RFLP map for 2q33-q37 from multicase mycobacterial and leishmanial disease families: no evidence for an Lsh/Ity/Bcg gene homologue influencing susceptibility to leprosy. Ann Hum Genet 1993; 57:251-71.